Pharmasset

December 16, 2016

Hep C settlement pays Merck’s Idenix bill

September 22, 2016

Bubble stocks top the takeover premium charts

September 07, 2016

How Gilead could go back to basics

September 14, 2015

Therapeutic focus – new combos and genotypes the future in hep C

June 30, 2015

Celgene goes for broke

November 27, 2014

Bristol-Myers misses out again in hep C

October 23, 2014

Data in 14 has Regulus joining ranks of hep C high flyers

September 30, 2014

J&J hangs in hep C game with $1.8bn Alios takeout

July 23, 2014

Sovaldi not the first to break the bank

June 09, 2014

Biotech bull market charges with Merck’s Idenix takeout

April 09, 2014

EASL – Cost tops the agenda as hepatitis C enters post-interferon world

Load More